Year |
Citation |
Score |
2024 |
Williams CH, Neitzel LR, Cornell J, Rea S, Mills I, Silver MS, Ahmad JD, Birukov KG, Birukova A, Brem H, Tyler B, Bar EE, Hong CC. GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment. Experimental Hematology & Oncology. 13: 13. PMID 38291540 DOI: 10.1186/s40164-023-00468-1 |
0.372 |
|
2022 |
Spina R, Mills I, Ahmad F, Chen C, Ames HM, Winkles JA, Woodworth GF, Bar EE. DHODH inhibition impedes glioma stem cell proliferation, induces DNA damage, and prolongs survival in orthotopic glioblastoma xenografts. Oncogene. PMID 36344676 DOI: 10.1038/s41388-022-02517-1 |
0.351 |
|
2021 |
Connolly NP, Galisteo R, Xu S, Bar EE, Peng S, Tran NL, Ames HM, Kim AJ, Woodworth GF, Winkles JA. Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer. Glia. PMID 33991013 DOI: 10.1002/glia.24018 |
0.419 |
|
2020 |
Yuan M, White D, Resar L, Bar E, Groves M, Cohen A, Jackson E, Bynum J, Rubens J, Mumm J, Chen L, Jiang L, Raabe E, Rodriguez F, Eberhart CG. Conditional reprograming culture conditions facilitate growth of lower grade glioma models. Neuro-Oncology. PMID 33258947 DOI: 10.1093/neuonc/noaa263 |
0.556 |
|
2020 |
Buyandelger B, Bar EE, Hung KS, Chen RM, Chiang YH, Liou JP, Huang HM, Wang JY. Histone deacetylase inhibitor MPT0B291 suppresses Glioma Growth and partially through acetylation of p53. International Journal of Biological Sciences. 16: 3184-3199. PMID 33162824 DOI: 10.7150/ijbs.45505 |
0.381 |
|
2020 |
Voss DM, Sloan A, Spina R, Ames HM, Bar EE. The Alternative Splicing Factor MBNL1 Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness. Cancer Research. PMID 32928918 DOI: 10.1158/0008-5472.CAN-20-1233 |
0.406 |
|
2020 |
Eberhart CG, Bar EE. Spatial enrichment of cellular states in glioblastoma. Acta Neuropathologica. PMID 32449056 DOI: 10.1007/S00401-020-02165-3 |
0.463 |
|
2019 |
Aguila B, Morris AB, Spina R, Bar E, Schraner J, Vinkler R, Sohn JW, Welford SM. The Ig superfamily protein PTGFRN coordinates survival signaling in Glioblastoma multiforme. Cancer Letters. PMID 31377205 DOI: 10.1016/J.Canlet.2019.07.018 |
0.43 |
|
2018 |
Gayle SS, Sahni JM, Webb BM, Weber-Bonk KL, Shively MS, Spina R, Bar EE, Summers MK, Keri RA. Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells. The Journal of Biological Chemistry. PMID 30482844 DOI: 10.1074/Jbc.Ra118.004712 |
0.309 |
|
2018 |
Spina R, Voss DM, Asnaghi L, Sloan A, Bar EE. Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells. Journal of Visualized Experiments : Jove. PMID 29364250 DOI: 10.3791/56176 |
0.358 |
|
2018 |
Spina R, Voss D, Sohn JW, Vinkler R, Schraner J, Sloan A, Welford S, Bar E. Stem-19. Monocarboxylate Transporter-4 Depletion Inhibits Stemness, Promotes Dna Damage And Radiosensitizes Glioblastoma Stem Cells Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.1026 |
0.379 |
|
2017 |
Boyd NH, Walker K, Fried J, Hackney JR, McDonald PC, Benavides GA, Spina R, Audia A, Scott SE, Libby CJ, Tran AN, Bevensee MO, Griguer C, Nozell S, Gillespie GY, ... ... Bar EE, et al. Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. Jci Insight. 2. PMID 29263302 DOI: 10.1172/Jci.Insight.92928 |
0.4 |
|
2017 |
Voss DM, Spina R, Carter DL, Suan Lim K, Jeffery CJ, Bar EE. Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression. Scientific Reports. 7: 4292. PMID 28655889 DOI: 10.1038/S41598-017-04612-W |
0.375 |
|
2017 |
Zhang Y, Cruickshanks N, Yuan F, Wang B, Pahuski M, Wulfkuhle J, Gallagher I, Koeppel AF, Hatef S, Papanicolas C, Lee J, Bar EE, Schiff D, Turner S, Petricoin EF, et al. Targetable T-type calcium channels drive glioblastoma. Cancer Research. PMID 28512247 DOI: 10.1158/0008-5472.Can-16-2347 |
0.386 |
|
2015 |
Spina R, Voss DM, Asnaghi L, Sloan A, Bar EE. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells. Oncotarget. PMID 26575950 DOI: 10.18632/oncotarget.6314 |
0.433 |
|
2015 |
Brandt WD, Schreck KC, Bar EE, Taylor I, Marchionni L, Raabe E, Eberhart CG, Rodriguez FJ. Notch signaling activation in pediatric low-grade astrocytoma. Journal of Neuropathology and Experimental Neurology. 74: 121-31. PMID 25575134 DOI: 10.1097/Nen.0000000000000155 |
0.626 |
|
2015 |
Lim KJ, Brandt WD, Heth JA, Muraszko KM, Fan X, Bar EE, Eberhart CG. Lateral inhibition of Notch signaling in neoplastic cells. Oncotarget. 6: 1666-77. PMID 25557173 DOI: 10.18632/Oncotarget.2762 |
0.627 |
|
2015 |
Spina R, Voss D, Sloan A, Bar E. Stem-03Atracurium Besylate And Other Neuromuscular Blocking Agents Promote Astroglial Differentiation And Deplete Glioblastoma Stem Cells. Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov234.03 |
0.511 |
|
2014 |
Kahlert UD, Suwala AK, Raabe EH, Siebzehnrubl FA, Suarez MJ, Orr BA, Bar EE, Maciaczyk J, Eberhart CG. ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres. Brain Pathology (Zurich, Switzerland). PMID 25521330 DOI: 10.1111/Bpa.12240 |
0.661 |
|
2014 |
Brett-Morris A, Wright BM, Seo Y, Pasupuleti V, Zhang J, Lu J, Spina R, Bar EE, Gujrati M, Schur R, Lu ZR, Welford SM. The polyamine catabolic enzyme SAT1 modulates tumorigenesis and radiation response in GBM. Cancer Research. 74: 6925-34. PMID 25277523 DOI: 10.1158/0008-5472.Can-14-1249 |
0.339 |
|
2014 |
Asnaghi L, Lin MH, Lim KS, Lim KJ, Tripathy A, Wendeborn M, Merbs SL, Handa JT, Sodhi A, Bar EE, Eberhart CG. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation. Plos One. 9: e105372. PMID 25166211 DOI: 10.1371/Journal.Pone.0105372 |
0.588 |
|
2014 |
Lim KS, Lim KJ, Price AC, Orr BA, Eberhart CG, Bar EE. Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner. Oncogene. 33: 4433-41. PMID 24077291 DOI: 10.1038/Onc.2013.390 |
0.654 |
|
2014 |
Brett-Morris A, Welford SM, Bar E, Spina R, Wright B, Zhang J, Lu J, Seo Y. Abstract 3954: SAT1 (Spermidine/spermine-N1-acetyltrasferase 1) promotes radiation resistance in glioblastoma multiforme Cancer Research. 74: 3954-3954. DOI: 10.1158/1538-7445.Am2014-3954 |
0.421 |
|
2013 |
Spina R, Filocamo G, Iaccino E, Scicchitano S, Lupia M, Chiarella E, Mega T, Bernaudo F, Pelaggi D, Mesuraca M, Pazzaglia S, Semenkow S, Bar EE, Kool M, Pfister S, et al. Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. Oncotarget. 4: 1280-92. PMID 23907569 DOI: 10.18632/Oncotarget.1176 |
0.643 |
|
2013 |
Chu Q, Orr BA, Semenkow S, Bar EE, Eberhart CG. Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3224-33. PMID 23630166 DOI: 10.1158/1078-0432.Ccr-12-2119 |
0.672 |
|
2013 |
Ho CY, Bar E, Giannini C, Marchionni L, Karajannis MA, Zagzag D, Gutmann DH, Eberhart CG, Rodriguez FJ. MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. Neuro-Oncology. 15: 69-82. PMID 23161775 DOI: 10.1093/Neuonc/Nos269 |
0.541 |
|
2012 |
Kahlert UD, Bender NO, Maciaczyk D, Bogiel T, Bar EE, Eberhart CG, Nikkhah G, Maciaczyk J. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component. Folia Neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences. 50: 357-68. PMID 23319191 DOI: 10.5114/Fn.2012.32365 |
0.61 |
|
2012 |
Asnaghi L, Ebrahimi KB, Schreck KC, Bar EE, Coonfield ML, Bell WR, Handa J, Merbs SL, Harbour JW, Eberhart CG. Notch signaling promotes growth and invasion in uveal melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 654-65. PMID 22228632 DOI: 10.1158/1078-0432.Ccr-11-1406 |
0.641 |
|
2012 |
Lin A, Rodriguez FJ, Karajannis MA, Williams SC, Legault G, Zagzag D, Burger PC, Allen JC, Eberhart CG, Bar EE. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. Journal of Neuropathology and Experimental Neurology. 71: 66-72. PMID 22157620 DOI: 10.1097/Nen.0B013E31823F2Cb0 |
0.585 |
|
2012 |
Kozono D, Nitta M, Sampetrean O, Kimberly N, Kushwaha D, Merzon D, Ligon K, Zhu S, Zhu K, Kim TH, Kwon C, Becher O, Saya H, Chen CC, Donovan LK, ... ... Bar E, et al. LAB-STEM CELLS Neuro-Oncology. 14: vi142-vi152. DOI: 10.1093/Neuonc/Nos239 |
0.611 |
|
2011 |
Raabe EH, Lim KS, Kim JM, Meeker A, Mao XG, Nikkhah G, Maciaczyk J, Kahlert U, Jain D, Bar E, Cohen KJ, Eberhart CG. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3590-9. PMID 21636552 DOI: 10.1158/1078-0432.Ccr-10-3349 |
0.698 |
|
2011 |
Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biology & Therapy. 11: 464-73. PMID 21193839 DOI: 10.4161/Cbt.11.5.14410 |
0.675 |
|
2011 |
Bar EE. Glioblastoma, cancer stem cells and hypoxia. Brain Pathology (Zurich, Switzerland). 21: 119-29. PMID 21054626 DOI: 10.1111/j.1750-3639.2010.00460.x |
0.397 |
|
2011 |
Raabe EH, Lim KS, Mao X, Bar E, Meeker A, Kahlert U, Maciaczyk J, Nikkhah G, Eberhart CG. Abstract 3303: BRAF activation induces cellular transformation and senescence and down-regulates SOX2 in human neural stem cells: a model of pilocytic astrocytoma Cancer Research. 71: 3303-3303. DOI: 10.1158/1538-7445.Am2011-3303 |
0.68 |
|
2010 |
Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N, Eberhart CG. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 6060-70. PMID 21169257 DOI: 10.1158/1078-0432.Ccr-10-1624 |
0.668 |
|
2010 |
Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. The American Journal of Pathology. 177: 1491-502. PMID 20671264 DOI: 10.2353/Ajpath.2010.091021 |
0.666 |
|
2010 |
Lim KJ, Maitra A, Bisht S, Eberhart C, Bar E. Abstract 4440: Using nanocurcumin to treat medulloblastoma and glioblastoma Cancer Research. 70: 4440-4440. DOI: 10.1158/1538-7445.Am10-4440 |
0.696 |
|
2009 |
Nasonkin I, Mahairaki V, Xu L, Hatfield G, Cummings BJ, Eberhart C, Ryugo DK, Maric D, Bar E, Koliatsos VE. Long-term, stable differentiation of human embryonic stem cell-derived neural precursors grafted into the adult mammalian neostriatum. Stem Cells (Dayton, Ohio). 27: 2414-26. PMID 19609935 DOI: 10.1002/Stem.177 |
0.594 |
|
2008 |
Bar EE, Lin A, Tihan T, Burger PC, Eberhart CG. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. Journal of Neuropathology and Experimental Neurology. 67: 878-87. PMID 18716556 DOI: 10.1097/Nen.0B013E3181845622 |
0.543 |
|
2007 |
Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W, Piccirillo S, Vescovi AL, DiMeco F, Olivi A, Eberhart CG. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (Dayton, Ohio). 25: 2524-33. PMID 17628016 DOI: 10.1634/Stemcells.2007-0166 |
0.69 |
|
2007 |
Bar EE, Chaudhry A, Farah MH, Eberhart CG. Hedgehog signaling promotes medulloblastoma survival via Bc/II. The American Journal of Pathology. 170: 347-55. PMID 17200206 DOI: 10.2353/Ajpath.2007.060066 |
0.624 |
|
Show low-probability matches. |